Atea Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 8.99 M | $30.12 M | 100.00% | 10.65% |
BML CAPITAL MANAGEMENT, LLC | 11/05/2024 | 6.65 M | $22.28 M | 4.30% | 7.88% |
FMR LLC | 11/13/2024 | 6.62 M | $22.17 M | 2.83% | 7.84% |
ECOR1 CAPITAL, LLC | 11/14/2024 | 5.44 M | $18.23 M | 0.00% | 6.45% |
VANGUARD GROUP INC | 11/13/2024 | 4.85 M | $16.25 M | 2.68% | 5.75% |
TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 4.61 M | $15.43 M | 2.91% | 5.46% |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2024 | 2.49 M | $8.33 M | 0.00% | 2.94% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.92 M | $6.45 M | -4.23% | 2.28% |
STATE STREET CORP | 11/14/2024 | 1.73 M | $5.81 M | 0.67% | 2.05% |
ALMITAS CAPITAL LLC | 11/14/2024 | 1.38 M | $4.64 M | 7.31% | 1.64% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.21 M | $4.04 M | 5.75% | 1.43% |
ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 932,925 | $3.12 M | -0.17% | 1.11% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 793,626 | $2.66 M | 33.53% | 0.94% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 650,157 | $2.18 M | 8.47% | 0.77% |
CITADEL ADVISORS LLC | 11/14/2024 | 595,249 | $1.99 M | 13.25% | 0.71% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 582,400 | $1.95 M | -4.87% | 0.69% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 509,471 | $1.71 M | -9.81% | 0.60% |
MORGAN STANLEY | 11/14/2024 | 488,899 | $1.64 M | 33.02% | 0.58% |
NEWTYN MANAGEMENT, LLC | 11/14/2024 | 380,000 | $1.27 M | 0.00% | 0.45% |
BANQUE PICTET & CIE SA | 10/21/2024 | 345,077 | $1.16 M | 0.00% | 0.41% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 341,761 | $1.14 M | -8.88% | 0.40% |
ACUITAS INVESTMENTS, LLC | 11/07/2024 | 323,542 | $1.08 M | 24.78% | 0.38% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 300,928 | $1.01 M | 35.96% | 0.36% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 291,091 | $975,154 | 0.00% | 0.34% |
CM MANAGEMENT, LLC | 11/12/2024 | 270,000 | $904,500 | 0.00% | 0.32% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 221,562 | $742,233 | -13.17% | 0.26% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 212,690 | $712,512 | -20.10% | 0.25% |
INVESCO LTD. | 11/12/2024 | 194,529 | $651,672 | -0.26% | 0.23% |
D. E. SHAW & CO., INC. | 11/14/2024 | 193,578 | $648,486 | 30.87% | 0.23% |
BARCLAYS PLC | 11/19/2024 | 177,077 | $593,000 | 74.54% | 0.21% |
AUOUR INVESTMENTS LLC | 10/30/2024 | 177,000 | $600,030 | 0.00% | 0.21% |
RBF CAPITAL, LLC | 11/14/2024 | 148,451 | $496,714 | 0.00% | 0.18% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 143,196 | $479,707 | 14.40% | 0.17% |
RHUMBLINE ADVISERS | 11/12/2024 | 133,114 | $445,919 | -3.26% | 0.16% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 119,220 | $399,387 | 0.00% | 0.14% |
STATE OF WISCONSIN INVESTMENT BOARD | 11/14/2024 | 109,200 | $365,820 | -23.80% | 0.13% |
STRS OHIO | 11/01/2024 | 105,500 | $353,425 | 0.00% | 0.13% |
WOODLINE PARTNERS LP | 11/14/2024 | 103,358 | $346,249 | 100.00% | 0.12% |
AMERIPRISE FINANCIAL INC | 11/14/2024 | 98,069 | $328,531 | -3.66% | 0.12% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 97,300 | $325,955 | -45.79% | 0.12% |
JPMORGAN CHASE & CO | 12/26/2024 | 95,244 | $319,067 | 106.08% | 0.11% |
JANE STREET GROUP, LLC | 11/15/2024 | 92,285 | $309,154 | -2.79% | 0.11% |
UBS GROUP AG | 11/14/2024 | 78,391 | $262,610 | 9.52% | 0.09% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 70,001 | $235,000 | 5.01% | 0.08% |
MACQUARIE GROUP LTD | 11/14/2024 | 70,000 | $235,000 | 0.00% | 0.08% |
BERKSHIRE ASSET MANAGEMENT LLC/PA | 11/14/2024 | 65,000 | $215,150 | 0.00% | 0.08% |
ALPS ADVISORS INC | 11/12/2024 | 64,692 | $216,718 | -1.50% | 0.08% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 59,539 | $199,455 | -14.30% | 0.07% |
VERITION FUND MANAGEMENT LLC | 11/14/2024 | 56,909 | $190,645 | -13.74% | 0.07% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 53,168 | $178,113 | -21.29% | 0.06% |
Atea Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 122 institutional investors and hedge funds held shares of Atea Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 8.99 M
BML Capital Management, LLC: 6.65 M
FMR LLC: 6.62 M
EcoR1 Capital, LLC: 5.44 M
VANGUARD GROUP INC: 4.85 M
TANG CAPITAL MANAGEMENT LLC: 4.61 M
68.59% of Atea Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 66.97 M shares in the last 24 months. This purchase volume represents approximately $224.36 M in transactions.